Patents by Inventor Natalia Nekhotiaeva

Natalia Nekhotiaeva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoline derivatives and their use as tyrosine kinase inhibitors
    Patent number: 8957092
    Abstract: A compound of formula 6-(methylcarbamoyl)-4-[(4-methylphenyl)amino]quinoline-3-carboxylic acid, and pharmaceutically acceptable salts thereof, is provided. The compound can be used to treat cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: February 17, 2015
    Assignee: ClanoTech AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
  • QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS
    Publication number: 20140018388
    Abstract: A compound of formula 6-(methylcarbamoyl)-4-[(4-methylphenyl)amino]quinoline-3-carboxylic acid, and pharmaceutically acceptable salts thereof, is provided. The compound can be used to treat cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.
    Type: Application
    Filed: August 30, 2013
    Publication date: January 16, 2014
    Applicant: Clano Tech AB
    Inventors: Jacob WESTMAN, Natalia NEKHOTIAEVA, Johan WANNBERG, Ulrika BACKMAN, Johan MALM
  • Quinoline derivatives and their use as tyrosine kinase inhibitors
    Patent number: 8557843
    Abstract: A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: October 15, 2013
    Assignee: ClanoTech AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
  • QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS
    Publication number: 20110053976
    Abstract: A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
    Type: Application
    Filed: November 14, 2008
    Publication date: March 3, 2011
    Applicant: CLANOTECH AB
    Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm